Addus HomeCare (NASDAQ:ADUS) Price Target Raised to $145.00

Addus HomeCare (NASDAQ:ADUS) had its price objective boosted by research analysts at Stephens from $143.00 to $145.00 in a research note issued on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Stephens’ price target indicates a potential upside of 11.66% from the company’s previous close.

Several other equities research analysts also recently issued reports on the stock. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. TD Cowen upped their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Royal Bank of Canada decreased their price objective on shares of Addus HomeCare from $141.00 to $136.00 and set an “outperform” rating for the company in a report on Wednesday. KeyCorp began coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research report on Monday. One research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $131.63.

Addus HomeCare Stock Up 4.6 %

Shares of NASDAQ ADUS traded up $5.69 during midday trading on Wednesday, hitting $129.86. The stock had a trading volume of 88,343 shares, compared to its average volume of 131,441. Addus HomeCare has a 1-year low of $81.51 and a 1-year high of $136.12. The company has a fifty day moving average price of $129.77 and a 200 day moving average price of $120.85. The company has a market capitalization of $2.35 billion, a price-to-earnings ratio of 29.72, a PEG ratio of 2.29 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. The company had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter in the previous year, the firm posted $1.03 earnings per share. The firm’s quarterly revenue was up 7.1% on a year-over-year basis. On average, research analysts forecast that Addus HomeCare will post 4.57 EPS for the current year.

Insider Transactions at Addus HomeCare

In other news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the sale, the director now owns 3,366 shares of the company’s stock, valued at $429,165. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares in the company, valued at approximately $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,917 shares of company stock worth $3,050,082. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Point72 Asset Management L.P. boosted its holdings in Addus HomeCare by 73.4% during the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock worth $86,598,000 after buying an additional 315,602 shares in the last quarter. Millennium Management LLC boosted its stake in shares of Addus HomeCare by 412.7% during the 2nd quarter. Millennium Management LLC now owns 316,418 shares of the company’s stock worth $36,739,000 after acquiring an additional 254,705 shares in the last quarter. Boston Partners acquired a new position in shares of Addus HomeCare in the 1st quarter worth $12,215,000. Ghisallo Capital Management LLC acquired a new stake in shares of Addus HomeCare during the second quarter worth $11,611,000. Finally, Lord Abbett & CO. LLC purchased a new stake in shares of Addus HomeCare during the first quarter valued at $8,274,000. Institutional investors own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.